JP2002519330A5 - - Google Patents

Download PDF

Info

Publication number
JP2002519330A5
JP2002519330A5 JP2000556793A JP2000556793A JP2002519330A5 JP 2002519330 A5 JP2002519330 A5 JP 2002519330A5 JP 2000556793 A JP2000556793 A JP 2000556793A JP 2000556793 A JP2000556793 A JP 2000556793A JP 2002519330 A5 JP2002519330 A5 JP 2002519330A5
Authority
JP
Japan
Prior art keywords
saline solution
isotonic saline
molarity
mos
concerned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000556793A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002519330A (ja
Filing date
Publication date
Priority claimed from FR9808249A external-priority patent/FR2780284B1/fr
Application filed filed Critical
Publication of JP2002519330A publication Critical patent/JP2002519330A/ja
Publication of JP2002519330A5 publication Critical patent/JP2002519330A5/ja
Pending legal-status Critical Current

Links

JP2000556793A 1998-06-29 1999-06-29 等浸透性食塩水溶液、その製法及び当該溶液に基づく耳垢溶解剤 Pending JP2002519330A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR98/08249 1998-06-29
FR9808249A FR2780284B1 (fr) 1998-06-29 1998-06-29 Utilisation de solutions salines isoosmotiques, leur procede de preparation et medicaments cerumenolytiques a base de ces solutions
PCT/FR1999/001564 WO2000000208A1 (fr) 1998-06-29 1999-06-29 Utilisation de solutions salines isoosmotiques, leur procede de preparation et medicaments cerumenolytiques a base de ces solutions

Publications (2)

Publication Number Publication Date
JP2002519330A JP2002519330A (ja) 2002-07-02
JP2002519330A5 true JP2002519330A5 (cg-RX-API-DMAC7.html) 2007-06-21

Family

ID=9528002

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000556793A Pending JP2002519330A (ja) 1998-06-29 1999-06-29 等浸透性食塩水溶液、その製法及び当該溶液に基づく耳垢溶解剤

Country Status (12)

Country Link
US (1) US6709680B1 (cg-RX-API-DMAC7.html)
EP (1) EP1091746B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002519330A (cg-RX-API-DMAC7.html)
AT (1) ATE212553T1 (cg-RX-API-DMAC7.html)
AU (1) AU4376599A (cg-RX-API-DMAC7.html)
CA (1) CA2335913C (cg-RX-API-DMAC7.html)
DE (1) DE69900852T2 (cg-RX-API-DMAC7.html)
DK (1) DK1091746T3 (cg-RX-API-DMAC7.html)
ES (1) ES2172332T3 (cg-RX-API-DMAC7.html)
FR (1) FR2780284B1 (cg-RX-API-DMAC7.html)
PT (1) PT1091746E (cg-RX-API-DMAC7.html)
WO (1) WO2000000208A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803205B1 (fr) * 1999-12-31 2002-10-18 Goemar Lab Sa Solutions ioniques aqueuses et leurs utilisations notamment en ophtalmologie
KR100785441B1 (ko) 2006-07-13 2007-12-13 주식회사 워터비스 해양 심층수 미네랄을 함유하는 항균성 생리식염수
FR2915389B1 (fr) * 2007-04-26 2012-12-21 De La Mer Laboratoire Utilisation de solutions ioniques isoosmotiques a base d'eau de mer pour la fabrication de dispositifs medicaux pour la prevention des complications du rhume courant
US20090258091A1 (en) * 2008-04-09 2009-10-15 Marine Bio Co., Ltd. Compositions and methods for treating neurodegenerative diseases
AU2009253696A1 (en) 2008-05-30 2009-12-03 The University Of British Columbia Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling
FR2971713B1 (fr) 2011-02-18 2019-03-29 Laboratoire De La Mer Solution ionique aqueuse contenant de l'eau de mer et au moins un compose originellement non miscible a l'eau de mer.
WO2015129800A1 (ja) * 2014-02-26 2015-09-03 セオリアファーマ株式会社 ジオクチルソジウムスルホサクシネート耳鼻科用液剤
US10989716B2 (en) 2015-05-01 2021-04-27 The University Of British Columbia Biomarkers for the detection of acute rejection in heart transplantation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581226A (en) * 1983-04-07 1986-04-08 Dillon Richard S Method of treating sensitive animal tissue with a specially processed seawater solution
JP2912421B2 (ja) * 1990-05-10 1999-06-28 千寿製薬株式会社 水性液剤
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
FR2688133A1 (fr) * 1992-03-06 1993-09-10 Plantes Tropicales Lab Composition d'hygiene a base d'eau de mer.
FR2735021B1 (fr) * 1995-06-08 1998-02-27 Maugendre Renee Jane Procede de preparation d'eau de mer pour la desagregation du cerumen
FR2735980B1 (fr) * 1995-06-30 1997-09-12 Sun Trading Ltd Nouvelles preparations pour l'otologie et leur procede de preparation

Similar Documents

Publication Publication Date Title
TNSN02021A1 (fr) Derives de benzimidazole nouveaux, et compositions les contenant
JP2001514931A5 (cg-RX-API-DMAC7.html)
DE602004026053D1 (cg-RX-API-DMAC7.html)
EP2269610A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
MX2007003327A (es) Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
MA29692B1 (fr) Derives de la xanthine en tant qu'agonistes selectifs du hm74a
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
EA200501322A1 (ru) Органические соединения железа (iii), их применение и способы получения указанных соединений
EP2266569A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
WO2002020466B1 (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
JP2002535332A5 (cg-RX-API-DMAC7.html)
TNSN07275A1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
AP1635A (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease.
ATE275397T1 (de) Zusammensetzungen, enthaltend blocker des renalen zelltransfers von l-dopa zur behandlung der parkinson-krankheit
BG108495A (en) 5-ht receptor ligands and uses thereof
EP1153620A3 (en) Solid compositions exhibiting selective binding to dissolved iron
JO2371B1 (en) 4-phenyl-pyridine derivatives
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
JP2002541255A5 (cg-RX-API-DMAC7.html)
TNSN01131A1 (fr) Derives de phenoxybenzylamine nouveaux, procede pour leur preparation et compositions les contenant.
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
ATE455859T1 (de) Herstellung von 5'-ribonukleotiden
JP2007537301A5 (cg-RX-API-DMAC7.html)
TNSN00112A1 (fr) Suspensions de ziprasidone nouvelles et procede pour leur preparation.
TNSN01046A1 (fr) Ethers de diphenyle utiles en therapeutique